Plain-English translation of NCT07546032 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing PROXERA PSOMED 30, a topical cream containing 30% urea, to see if it can improve nail psoriasis better than a simple moisturizer. You would apply the medication to one fingernail or toenail and petroleum jelly to a similar nail on the opposite hand or foot, comparing how each treatment works over six months.
Nail psoriasis is difficult to treat, and many patients don't have good options. This study aims to find out whether this medication can safely and effectively reduce the signs of nail psoriasis.
You likely qualify if…
You likely don't qualify if…
You would attend the study clinic at baseline and after 4, 12, and 24 weeks. At each visit, researchers would photograph your treated nails and score them on a severity scale. You would apply the urea cream to one target nail and petroleum jelly to the matching nail on the opposite hand or foot twice daily at home for the entire 24-week period, and report any irritation or concerns.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Italy
Sponsor
ICIM International S.r.l.
Enrollment target
~21 participants
Started
May 2026
Primary completion
February 2027
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Paolo Amerio, Professore Ordinario
ICIM International S.r.l.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.